We are live on ! Find out more
HM

HealthCor Management Portfolio holdings

AUM $109M
1-Year Est. Return 10.64%
This Fund
S&P 500
This Quarter Est. Return
-0.05%
1 Year Est. Return
+10.64%
3 Year Est. Return
+50.22%
5 Year Est. Return
+140.3%
10 Year Est. Return
–
AUM
$3.07B
AUM Growth
+$88.4M
Cap. Flow
+$123M
Cap. Flow %
3.99%
Top 10 Hldgs %
53.1%
Holding
48
New
8
Increased
13
Reduced
15
Closed
11

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$186M
2
MDT icon
Medtronic
MDT
+$151M
3
CELG
Celgene Corp
CELG
+$133M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$132M
5
BAX icon
Baxter International
BAX
+$111M

Top Sells

Rank Stock Value
1
AET
Aetna Inc
AET
+$180M
2
DHR icon
Danaher
DHR
+$103M
3
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
+$78.6M
4
LH icon
Labcorp
LH
+$72.6M
5
JNJ icon
Johnson & Johnson
JNJ
+$68M

Sector Composition

Rank Sector Weight
1 Healthcare 99.61%
2 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZTS icon
26
Zoetis
ZTS
$31.9B
$46.5M 1.51%
645,100
+246,460
+62% +$16.9M
THC icon
27
Tenet Healthcare
THC
$20.3B
$44.8M 1.46%
2,956,351
-1,575,581
-35% -$22.2M
JNJ icon
28
Johnson & Johnson
JNJ
$617B
$27.2M 0.89%
194,610
-488,440
-72% -$68M
SYK icon
29
Stryker
SYK
$133B
$25.7M 0.84%
+166,280
New +$25.4M
BMY icon
30
Bristol-Myers Squibb
BMY
$132B
$24.8M 0.81%
404,670
+113,530
+39% +$7.1M
CVRS
31
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
$20.2M 0.66%
19,981,655
– –
ABT icon
32
Abbott
ABT
$183B
$14M 0.46%
+244,950
New +$13.6M
ZBH icon
33
CALL
Zimmer Biomet
ZBH
$18.4B
$12.1M 0.39%
103,000
-154,500
-60% -$17.5M
DHR icon
34
Danaher
DHR
$138B
$11.6M 0.38%
140,616
-1,271,595
-90% -$103M
BSX icon
35
Boston Scientific
BSX
$68.4B
$9.12M 0.3%
367,832
-319,338
-46% -$8.81M
MNK
36
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$6.42M 0.21%
284,400
-2,930,279
-91% -$78.6M
FPRX
37
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$2.21M 0.07%
101,000
-909,930
-90% -$29.3M
EW icon
38
Edwards Lifesciences
EW
$50B
– –
-1,015,470
Closed -$37M
PFE icon
39
Pfizer
PFE
$142B
– –
-260,939
Closed -$8.84M
SPY icon
40
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$784B
– –
-1,000,000
Closed -$251M
SRPT icon
41
CALL
Sarepta Therapeutics
SRPT
$1.64B
– –
-235,000
Closed -$10.7M
XLV icon
42
State Street Health Care Select Sector SPDR ETF
XLV
$42.2B
– –
-353,960
Closed -$28.9M
SYNH
43
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
– –
-930,582
Closed -$48.7M
HRC
44
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
– –
-584,770
Closed -$43.3M
VAR
45
PUT
DELISTED
Varian Medical Systems, Inc.
VAR
– –
-500,000
Closed -$50M
MNK
46
CALL
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
– –
-800,000
Closed -$29.9M
AGN
47
CALL
DELISTED
Allergan plc
AGN
– –
-150,000
Closed -$30.7M
AET
48
DELISTED
Aetna Inc
AET
– –
-1,131,674
Closed -$180M
1
2

Similar funds

IA
Integrity Advisory Overland Park, Kansas $109M AUM 15.71% 1-Year Est. Return
EPC
Emerson Point Capital Larchmont, New York $108M AUM 19.03% 1-Year Est. Return
TCMV
Technology Crossover Management VII Menlo Park, California $107M AUM 51.05% 1-Year Est. Return
SI
Salesforce Inc San Francisco, California $114M AUM 53.18% 1-Year Est. Return
HCWM
Harrison & Co Wealth Management Roanoke, Virginia $103M AUM 9.82% 1-Year Est. Return
PC
Phoenician Capital New York $117M AUM 9.46% 1-Year Est. Return
RF
Resolute Financial Newburyport, Massachusetts $118M AUM 11.75% 1-Year Est. Return
AWM
Align Wealth Management Oklahoma City, Oklahoma $118M AUM

HealthCor Management's Q4 2017 Portfolio in Review

As of Q4 2017, HealthCor Management held 48 positions worth $3.07B, up 3% from $2.98B the previous quarter. Its ten largest holdings account for 53% of the portfolio.

HealthCor Management deployed $123M of net new capital in Q4 2017, opening 8 new positions and adding to 13 existing holdings. Its largest new stake was Regeneron Pharmaceuticals: 325,000 shares worth $122M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 78% a quarter earlier, followed by Financials.

On the sell side, the largest reduction was Danaher, an estimated $103M trimmed.

  • HealthCor Management's largest Q4 2017 buy was Regeneron Pharmaceuticals: 325,000 shares worth $122M.
  • HealthCor Management added most to Merck in Q4 2017, an estimated $186M increase.
  • HealthCor Management's biggest Q4 2017 reduction was Danaher, cutting an estimated $103M.
  • HealthCor Management fully exited Aetna Inc in Q4 2017, selling an estimated $180M.
  • HealthCor Management's ten largest holdings make up 53% of its $3.07B portfolio in Q4 2017.
  • HealthCor Management opened 8 new positions and closed 11 in Q4 2017.
  • HealthCor Management's portfolio value rose 3% quarter-over-quarter to $3.07B.

Based on HealthCor Management's 13F filing for Q4 2017, filed 14 Feb 2018.